Browsing Tag
Ltd.
56 posts
Why Sumitomo Forestry Co., Ltd.’s $47-per-share Tri Pointe Homes bet could shake up U.S. housing
Find out how Sumitomo Forestry’s Tri Pointe Homes acquisition could reshape U.S. homebuilding scale, strategy, and competition today!
ACROBiosystems just removed a quiet bottleneck in drug discovery. Will biopharma buyers notice?
Biopharma wants faster R&D, but compliance still slows labs. ACROBiosystems is turning HEK293 licensing into a workflow advantage.
ECOLINE bets on K-sauce as sweet heat becomes the next global food battleground
K-food wants pantry permanence, not trend status. ECOLINE’s K-sauce push tests whether gochujang can move into global kitchens.
Wenda Pharma’s NHWD-870 breakthrough tag puts rare NUT carcinoma therapy in sharper focus
A rare cancer has few targeted options. Wenda Pharma’s NHWD-870 now tests whether China can move faster in precision oncology.
What Everlert, Inc.’s Bolivia mining merger could mean for future OTC gold and copper valuations
Everlert, Inc. is rebranding as American Gold & Copper Inc. ahead of a Bolivia mining merger. Discover what it could mean for OTC valuations.
Samsung Electronics stock surges as $1tn valuation puts AI memory in focus
AI needs memory, not just GPUs. Samsung Electronics’ $1 trillion moment shows where investors think the next chip bottleneck sits.
Foxconn wants more than factories. Its new LEO satellites show where it may be heading
Foxconn is testing space ambitions beyond electronics. PEARL satellites may reveal whether 2317.TW can scale LEO manufacturing.
GAC Tech Day 2026 reveals how Guangzhou Automobile Group wants to compete on system control, not just product launches
Guangzhou Automobile Group’s Tech Day 2026 revealed five core technologies. Read how its hybrid, chip, and software push could reshape smart mobility.
JinkoSolar (NYSE: JKS) targets China’s weak-roof solar market with new Light Diamond module
JinkoSolar has launched a lightweight solar module aimed at load-restricted roofs. Read how this could open a new rooftop market and shape growth.
Why SK Life Science Labs’ AACR 2026 data could put targeted protein degradation back in the oncology spotlight
SK Life Science Labs unveiled new AACR 2026 preclinical data on p300 and PRMT5 degraders. Read why this oncology strategy could matter next.